RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC-4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S ANNUAL MEETING REINFORCE THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN CUSHING’S DISEASE 03/23/2021 Shortage of DESOXYN (methamphetamine hydrochloride tablets, USP) 5mg 02/26/2021 RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia 01/26/2021 Pagination First page « First Previous page ‹ Previous … Page 5 Current page 6 Page 7 Page 8 … Next page Next › Last page Last »
RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC-4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S ANNUAL MEETING REINFORCE THE EFFICACY AND SAFETY OF ISTURISA® (OSILODROSTAT) IN CUSHING’S DISEASE 03/23/2021
RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia 01/26/2021
